How The Regulatory Landscape Is Shaping The Future Of E-Pharmacy
The growth of e-pharmacy in India has been significant in recent years. The market is expected to reach around INR 90 Bn in 2027.
Stay updated with breaking news from Drug Controller General. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The growth of e-pharmacy in India has been significant in recent years. The market is expected to reach around INR 90 Bn in 2027.
NEW DELHI: In a major development, the Central government has suspended the licence of 18 pharma companies in the country over the poor quality of drugs. A top official source on Tuesday said that the Drug Controller General of India had inspected 76 companies and the licence of 18 have been suspended, while 26 have been served show cause notice over poor quality of drugs. The Centre has also cancelled the product permission of three pharma companies. In a joint operation by Centre and the states, the action was taken against pharma companies across 20 states. The special drive had been initia...
The panel was ‘appalled’ that draft rules for the online sale of medicines had not been finalised till date.
Under the drive, the licences of 18 firms have either been cancelled or suspended. Sources have claimed that the latest action might be led to the closure of some Pharmaceutical companies found making spurious or contaminated drugs.
Under the drive, licences of 18 firms have either been cancelled or suspended.